Alessia Parodi

2, L.B. Alberti Street
Genoa, 16132, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Immunoregulatory properties of cell free DNA.

Immunoregulatory properties of cell free DNA.

Journal: Cellular and molecular life sciences : CMLS

Published: October 11, 2024

Comparing Outcomes Between CPX-351 and Fludarabine-Based Induction in Secondary Acute Myeloid Leukemia in the Real-World Setting: The Prognostic Role of Measurable Residual Disease.

Comparing Outcomes Between CPX-351 and Fludarabine-Based Induction in Secondary Acute Myeloid Leukemia in the Real-World Setting: The Prognostic Role of Measurable Residual Disease.

Journal: Hematological oncology

Published: September 13, 2024

Early CAR- CD4+ T-lymphocytes recovery following CAR-T cell infusion: A worse outcome in diffuse large B cell lymphoma.

Early CAR- CD4+ T-lymphocytes recovery following CAR-T cell infusion: A worse outcome in diffuse large B cell lymphoma.

Journal: EJHaem

Published: January 22, 2024

Distinct features of immune activation and exhaustion markers in people with perinatally acquired HIV.

Distinct features of immune activation and exhaustion markers in people with perinatally acquired HIV.

Journal: AIDS (London, England)

Published: January 10, 2024

The fading guardian: clinical relevance of TP53 null mutation in high-grade serous ovarian cancers.

The fading guardian: clinical relevance of TP53 null mutation in high-grade serous ovarian cancers.

Journal: Frontiers in immunology

Published: May 12, 2023

Histopathological and Immunohistochemical Prognostic Factors in High-Grade Non-Endometrioid Carcinomas of the Endometrium (HG-NECs): Is It Possible to Identify Subgroups at Increased Risk?

Histopathological and Immunohistochemical Prognostic Factors in High-Grade Non-Endometrioid Carcinomas of the Endometrium (HG-NECs): Is It Possible to Identify Subgroups at Increased Risk?

Journal: Diagnostics (Basel, Switzerland)

Published: May 02, 2023

Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells.

Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells.

Journal: Journal of experimental & clinical cancer research : CR

Published: December 23, 2022

Longitudinal Cluster Analysis of Hemodialysis Patients with COVID-19 in the Pre-Vaccination Era.

Longitudinal Cluster Analysis of Hemodialysis Patients with COVID-19 in the Pre-Vaccination Era.

Journal: Life (Basel, Switzerland)

Published: September 27, 2022

Intermediate monocytes expansion and homing markers expression in COVID-19 patients associate with kidney dysfunction.

Intermediate monocytes expansion and homing markers expression in COVID-19 patients associate with kidney dysfunction.

Journal: Clinical and experimental medicine

Published: May 25, 2022

Telomerase-based GX301 cancer vaccine in patients with metastatic castration-resistant prostate cancer: a randomized phase II trial.

Telomerase-based GX301 cancer vaccine in patients with metastatic castration-resistant prostate cancer: a randomized phase II trial.

Journal: Cancer immunology, immunotherapy : CII

Published: March 19, 2021

Characterization of T lymphocytes in severe COVID-19 patients.

Characterization of T lymphocytes in severe COVID-19 patients.

Journal: Journal of medical virology

Published: March 08, 2021

Development of Exhaustion and Acquisition of Regulatory Function by Infiltrating CD8+CD28- T Lymphocytes Dictate Clinical Outcome in Head and Neck Cancer.

Development of Exhaustion and Acquisition of Regulatory Function by Infiltrating CD8+CD28- T Lymphocytes Dictate Clinical Outcome in Head and Neck Cancer.

Journal: Cancers

Published: February 23, 2021

Showing 1-12 of 45

Last Updated: 09/26/2026